Flagship Harbor Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-210
Closed -$2.48K 939
2025
Q4
$2.48K Buy
+210
New +$2.7K ﹤0.01% 1813
2020
Q4
Sell
-250
Closed -$5K 721
2020
Q3
$5K Sell
250
-10
-4% -$193 ﹤0.01% 1518
2020
Q2
$3K Sell
260
-53
-17% -$670 ﹤0.01% 1698
2020
Q1
$3K Sell
313
-966
-76% -$13.9K ﹤0.01% 1523
2019
Q4
$23K Sell
1,279
-43
-3% -$714 ﹤0.01% 1061
2019
Q3
$19K Sell
1,322
-133
-9% -$2.16K ﹤0.01% 1100
2019
Q2
$34K Sell
1,455
-160
-10% -$4.71K 0.01% 882
2019
Q1
$60K Sell
1,615
-101
-6% -$3.67K 0.01% 704
2018
Q4
$48K Buy
1,716
+20
+1% +$633 0.01% 727
2018
Q3
$67K Sell
1,696
-227
-12% -$9.93K 0.01% 704
2018
Q2
$85K Buy
+1,923
New +$95.7K 0.02% 626

Other funds holding CC

Flagship Harbor Advisors's CC Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Chemours (CC) in Q1 2026, closing a stake of 210 shares — an estimated $2.48K sold.

Flagship Harbor Advisors first reported a position in CC in Q2 2018 and held it in 11 quarters. The position peaked at $85K in Q2 2018. 450 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Chemours position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 210 Chemours shares in Q1 2026, an estimated $2.48K.
  • Flagship Harbor Advisors first reported a position in Chemours in Q2 2018 and held it in 11 quarters.
  • Flagship Harbor Advisors's Chemours position peaked at $85K in Q2 2018.
  • 450 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.